The following table presents the
number of shares subject to outstanding warrants, stock options, RSUs, convertible notes and Series A convertible preferred stock that
were excluded from the computation of diluted net loss per share of common stock for the three months ended March 31, 2025 and 2024, as
their effect was anti-dilutive (in thousands):
SCHEDULE OF COMPUTATION OF DILUTED
NET LOSS PER SHARE OF COMMON STOCK
| | |
2025 | | |
2024 | |
| | |
Three months ended March 31, | |
| | |
2025 | | |
2024 | |
| Stock options | |
| 4,460 | | |
| 2,085 | |
| Warrants | |
| 484 | | |
| 20,386 | |
| Preferred stock converted into common stock | |
| 68 | | |
| 19 | |
| Convertible Notes converted into common stock | |
| - | | |
| 7,945 | |
| RSUs | |
| - | | |
| 1 | |
| Total potential common shares excluded from computation | |
| 5,012 | | |
| 30,436 | |
|